drugset / Trial / NCT00447603

A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension (0954A-327)

NCT00447603 ↗

Phase 3 Terminated 40 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to test the safety and effectiveness of Losartan as compared to Losartan/HCTZ in pediatric patients (6 to 17 years) with high blood pressure.

Timeline

Start
2007-05-24
Primary completion
2007-10-22
Completion
2007-10-22

Outcome

Outcome not reported

Stopped (Enrollment): “Achieving site readiness and enrolling the trial within a reasonable time”

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrochlorothiazide Unknown 12.5 mg Oral
Comparator Losartan Other / unclassified 50 mg Oral
Comparator Losartan Other / unclassified 100 mg Oral

Indications